Skip to main content

Eslicarbazepine acetate

NDC 31722-430 · Camber Pharmaceuticals, Inc.

Generic nameEslicarbazepine acetate
Dosage formTABLET
RouteORAL
Active ingredient(s)ESLICARBAZEPINE ACETATE
Strength600 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

31722-430-32 — 10 BLISTER PACK in 1 CARTON (31722-430-32) / 10 TABLET in 1 BLISTER PACK (31722-430-31)

31722-430-60 — 60 TABLET in 1 BOTTLE (31722-430-60)

31722-430-90 — 90 TABLET in 1 BOTTLE (31722-430-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

13668-538 — Eslicarbazepine acetate, 13668-539 — Eslicarbazepine acetate, 13668-540 — Eslicarbazepine acetate, 13668-541 — Eslicarbazepine acetate, 31722-428 — Eslicarbazepine acetate, 31722-429 — Eslicarbazepine acetate, 31722-431 — Eslicarbazepine acetate, 43598-684 — Eslicarbazepine Acetate, 43598-685 — Eslicarbazepine Acetate, 43598-686 — Eslicarbazepine Acetate, 43598-687 — Eslicarbazepine Acetate, 51407-779 — Eslicarbazepine Acetate, 51407-780 — Eslicarbazepine Acetate, 51407-781 — Eslicarbazepine Acetate, 51407-782 — Eslicarbazepine Acetate, 59651-533 — ESLICARBAZEPINE ACETATE, 59651-534 — ESLICARBAZEPINE ACETATE, 59651-535 — ESLICARBAZEPINE ACETATE, 59651-536 — ESLICARBAZEPINE ACETATE, 59746-717 — eslicarbazepine acetate, +19 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.